Method of autoimmunity correction in ischemic heart disease
- Authors: Shanin V.Y.1, Shanina N.Y.1, Bogoslovskaya S.I.1, Elyutin D.V.1, Tsarenko T.P.1
-
Affiliations:
- Saratov State Medical University
- Issue: Vol 82, No 4 (2001)
- Pages: 241-245
- Section: Articles
- URL: https://bakhtiniada.ru/kazanmedj/article/view/83829
- DOI: https://doi.org/10.17816/kazmj83829
- ID: 83829
Cite item
Full Text
Abstract
The influence of a new enterosorbent-enterosgel on the immune and autoimmune process in the dynamics of ischemic heart disease and the possibilities of endogenic intoxication decrease using the given drug are estimated. The use of enterosgel made it possible to get the high therapeutic hypolipidemic and autoimmunocorrecting effect in patients with ischemic heart disease, expressed in the improvement of the state - the decrease of the frequency of stenocardia making it case of peace and effort making it possible to decrease daily nitroglycerine dose.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
V. Yu. Shanin
Saratov State Medical University
Author for correspondence.
Email: info@eco-vector.com
Russian Federation
N. Yu. Shanina
Saratov State Medical University
Email: info@eco-vector.com
Russian Federation
S. I. Bogoslovskaya
Saratov State Medical University
Email: info@eco-vector.com
Russian Federation
D. V. Elyutin
Saratov State Medical University
Email: info@eco-vector.com
Russian Federation
T. P. Tsarenko
Saratov State Medical University
Email: info@eco-vector.com
Russian Federation
References
Supplementary files
